 |
|
Long-term Antipsychotic Treatment and Brain VolumesA Longitudinal Study of First-Episode Schizophrenia
Beng-Choon Ho, MRCPsych;
Nancy C. Andreasen, MD, PhD;
Steven Ziebell, BS;
Ronald Pierson, MS;
Vincent Magnotta, PhD
Arch Gen Psychiatry. 2011;68(2):128-137. doi:10.1001/archgenpsychiatry.2010.199
Context Progressive brain volume changes in schizophrenia are thought to be due principally to the disease. However, recent animal studies indicate that antipsychotics, the mainstay of treatment for schizophrenia patients, may also contribute to brain tissue volume decrement. Because antipsychotics are prescribed for long periods for schizophrenia patients and have increasingly widespread use in other psychiatric disorders, it is imperative to determine their long-term effects on the human brain.
Objective To evaluate relative contributions of 4 potential predictors (illness duration, antipsychotic treatment, illness severity, and substance abuse) of brain volume change.
Design Predictors of brain volume changes were assessed prospectively based on multiple informants.
Setting Data from the Iowa Longitudinal Study.
Patients Two hundred eleven patients with schizophrenia who underwent repeated neuroimaging beginning soon after illness onset, yielding a total of 674 high-resolution magnetic resonance scans. On average, each patient had 3 scans ( 2 and as many as 5) over 7.2 years (up to 14 years).
Main Outcome Measure Brain volumes.
Results During longitudinal follow-up, antipsychotic treatment reflected national prescribing practices in 1991 through 2009. Longer follow-up correlated with smaller brain tissue volumes and larger cerebrospinal fluid volumes. Greater intensity of antipsychotic treatment was associated with indicators of generalized and specific brain tissue reduction after controlling for effects of the other 3 predictors. More antipsychotic treatment was associated with smaller gray matter volumes. Progressive decrement in white matter volume was most evident among patients who received more antipsychotic treatment. Illness severity had relatively modest correlations with tissue volume reduction, and alcohol/illicit drug misuse had no significant associations when effects of the other variables were adjusted.
Conclusions Viewed together with data from animal studies, our study suggests that antipsychotics have a subtle but measurable influence on brain tissue loss over time, suggesting the importance of careful risk-benefit review of dosage and duration of treatment as well as their off-label use.
Author Affiliations: Departments of Psychiatry (Drs Ho and Andreasen and Messrs Ziebell and Pierson) and Radiology (Dr Magnotta), University of Iowa Carver College of Medicine, Iowa City.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Antipsychotic Medications and Brain Volume: Do We Have Cause for Concern?
David A. Lewis
Arch Gen Psychiatry. 2011;68(2):126-127.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
Fusar-Poli and Meyer-Lindenberg
Schizophr Bull 2012;0:sbr180v1-sbr180.
ABSTRACT
| FULL TEXT
'Prodromal' diagnosis of psychosis: Ethical problems in research and clinical practice
Raven et al.
Aust N Z J Psychiatry 2012;46:64-65.
FULL TEXT
Progressive Brain Changes in Children and Adolescents With First-Episode Psychosis
Arango et al.
Arch Gen Psychiatry 2012;69:16-26.
ABSTRACT
| FULL TEXT
The Field of Schizophrenia: Strengths, Weaknesses, Opportunities, and Threats
Kane et al.
Schizophr Bull 2012;38:1-4.
FULL TEXT
Neuroanatomical Maps of Psychosis Onset: Voxel-wise Meta-Analysis of Antipsychotic-Naive VBM Studies
Fusar-Poli et al.
Schizophr Bull 2011;0:sbr134v2-sbr134.
ABSTRACT
| FULL TEXT
Changes in Cortical Thickness During the Course of Illness in Schizophrenia
van Haren et al.
Arch Gen Psychiatry 2011;68:871-880.
ABSTRACT
| FULL TEXT
Two points of clinical interest
Krishnadas
BMJ 2011;342:d2148-d2148.
FULL TEXT
It Can't Hurt to Lose Brain Volume, Can It?
JWatch Psychiatry 2011;2011:6-6.
FULL TEXT
Antipsychotic Medications and Brain Volume: Do We Have Cause for Concern?
Lewis
Arch Gen Psychiatry 2011;68:126-127.
FULL TEXT
RAPID RESPONSES TO THIS ARTICLE
On the benefits of antipsychotics in schizophrenia
Paul Hutton
Arch Gen Psychiatry Online, 22 Feb 2011.
TEXT
Brain Volume Loss and Neuroleptics
Lynn E. DeLisi
Arch Gen Psychiatry Online, 22 Feb 2011.
TEXT
Brain volume decline in first-episode schizophrenics
John J. Mooney, et al.
Arch Gen Psychiatry Online, 4 Mar 2011.
TEXT
|
